サンプル依頼リスト カート
  • English
  • Korean
表紙：造影剤注入システム市場：製品タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2021～2030年
市場調査レポート
商品コード
1365724

造影剤注入システム市場：製品タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2021～2030年

Contrast Injector Systems Market By Product Type, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2030
出版日: | 発行: Allied Market Research | ページ情報: 英文 212 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
造影剤注入システム市場：製品タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2021～2030年
出版日: 2023年08月01日
発行: Allied Market Research
ページ情報: 英文 212 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Allied Market Researchが発行した新しい調査レポート「造影剤注入システム市場」によると、造影剤注入システム市場は2020年に7億5,557万米ドルで、2021年から2030年にかけてCAGR 7.3%で成長し、2030年には15億米ドルに達すると予測されています。

世界の造影剤注入システム市場の成長を促進する主な要因としては、血管造影、コンピュータ断層撮影、磁気共鳴画像法などの造影剤注入装置を介した医療用画像処理プロセスの急速な利用が挙げられます。加えて、世界の高齢者人口の増加や慢性疾患の有病率の高さが市場成長を後押ししています。しかし、造影剤注入システムに関連する高コストと注入システムおよび造影剤に関連するリスクが市場成長を制限すると予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • 世界の慢性疾患の高蔓延に伴う高齢者人口の増加
    • 抑制要因
      • 造影剤注入システムの高コストと高リスク
    • 機会
      • 新興諸国における医療支出の急増と複合疾患の出現
  • COVID-19市場への影響分析

第4章 造影剤注入システム市場：製品タイプ別

  • 概要
  • 消耗品
  • インジェクターシステム
  • 付属品

第5章 造影剤注入システム市場：用途別

  • 概要
  • 放射線医学
  • インターベンショナル放射線学
  • インターベンショナルカーディオロジー

第6章 造影剤注入システム市場：エンドユーザー別

  • 概要
  • 病院
  • 診断センター
  • クリニック
  • その他

第7章 造影剤注入システム市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • その他

第8章 競争情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2020年

第9章 企業プロファイル

  • Bracco Imaging S.p.A
  • Bayer Healthcare LLC
  • Guerbet Group
  • Medtron AG
  • Ulrich GmbH & Co. KG
  • GE Healthcare
  • Shenzhen Seacrown Electromechanical Co., Ltd.
  • Nemoto Kyorindo Co. Ltd.
  • Sino Medical-Device Technology Co., Ltd.
  • Vivid Imaging
図表

LIST OF TABLES

  • TABLE 01. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 02. CONTRAST INJECTOR SYSTEMS MARKET FOR CONSUMABLES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 03. CONTRAST INJECTOR SYSTEMS MARKET FOR INJECTOR SYSTEMS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 04. CONTRAST INJECTOR SYSTEMS MARKET FOR ACCESSORIES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 05. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 06. CONTRAST INJECTOR SYSTEMS MARKET FOR RADIOLOGY, BY REGION, 2020-2030 ($MILLION)
  • TABLE 07. CONTRAST INJECTOR SYSTEMS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2020-2030 ($MILLION)
  • TABLE 08. CONTRAST INJECTOR SYSTEMS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2020-2030 ($MILLION)
  • TABLE 09. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 10. CONTRAST INJECTOR SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11. CONTRAST INJECTOR SYSTEMS MARKET FOR DIAGNOSTICS CENTERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12. CONTRAST INJECTOR SYSTEMS MARKET FOR CLINICS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 13. CONTRAST INJECTOR SYSTEMS MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 14. CONTRAST INJECTOR SYSTEMS MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 15. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 16. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 17. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 18. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 19. U.S. CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 20. U.S. CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 21. U.S. CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 22. CANADA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 23. CANADA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 24. CANADA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 25. MEXICO CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 26. MEXICO CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 27. MEXICO CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 28. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 29. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 30. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 31. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 32. GERMANY CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 33. GERMANY CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 34. GERMANY CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 35. FRANCE CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 36. FRANCE CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 37. FRANCE CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 38. U.K. CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 39. U.K. CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 40. U.K. CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 41. ITALY CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 42. ITALY CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 43. ITALY CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 44. SPAIN CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 45. SPAIN CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 46. SPAIN CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 47. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 48. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 49. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 50. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 51. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 52. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 53. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 54. JAPAN CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 55. JAPAN CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 56. JAPAN CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 57. CHINA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 58. CHINA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 59. CHINA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 60. INDIA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 61. INDIA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 62. INDIA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 63. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 64. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 65. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 66. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 69. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 70. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 71. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 72. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 73. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 74. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 75. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 76. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 77. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 78. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 79. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 80. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 81. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 82. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 83. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 84. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 85. BRACCO IMAGING S.P.A: KEY EXECUTIVES
  • TABLE 86. BRACCO IMAGING S.P.A: COMPANY SNAPSHOT
  • TABLE 87. BRACCO IMAGING S.P.A: PRODUCT SEGMENTS
  • TABLE 88. BRACCO IMAGING S.P.A: PRODUCT PORTFOLIO
  • TABLE 89. BAYER HEALTHCARE LLC: KEY EXECUTIVES
  • TABLE 90. BAYER HEALTHCARE LLC: COMPANY SNAPSHOT
  • TABLE 91. BAYER HEALTHCARE LLC: PRODUCT SEGMENTS
  • TABLE 92. BAYER HEALTHCARE LLC: PRODUCT PORTFOLIO
  • TABLE 93. GUERBET GROUP: KEY EXECUTIVES
  • TABLE 94. GUERBET GROUP: COMPANY SNAPSHOT
  • TABLE 95. GUERBET GROUP: PRODUCT SEGMENTS
  • TABLE 96. GUERBET GROUP: PRODUCT PORTFOLIO
  • TABLE 97. MEDTRON AG: KEY EXECUTIVES
  • TABLE 98. MEDTRON AG: COMPANY SNAPSHOT
  • TABLE 99. MEDTRON AG: PRODUCT SEGMENTS
  • TABLE 100. MEDTRON AG: PRODUCT PORTFOLIO
  • TABLE 101. ULRICH GMBH & CO. KG: KEY EXECUTIVES
  • TABLE 102. ULRICH GMBH & CO. KG: COMPANY SNAPSHOT
  • TABLE 103. ULRICH GMBH & CO. KG: PRODUCT SEGMENTS
  • TABLE 104. ULRICH GMBH & CO. KG: PRODUCT PORTFOLIO
  • TABLE 105. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 106. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 107. GE HEALTHCARE: SERVICE SEGMENTS
  • TABLE 108. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 109. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: KEY EXECUTIVES
  • TABLE 110. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY SNAPSHOT
  • TABLE 111. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCT SEGMENTS
  • TABLE 112. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 113. NEMOTO KYORINDO CO. LTD.: KEY EXECUTIVES
  • TABLE 114. NEMOTO KYORINDO CO. LTD.: COMPANY SNAPSHOT
  • TABLE 115. NEMOTO KYORINDO CO. LTD.: PRODUCT SEGMENTS
  • TABLE 116. NEMOTO KYORINDO CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 117. SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: KEY EXECUTIVES
  • TABLE 118. SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
  • TABLE 119. SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: PRODUCT SEGMENTS
  • TABLE 120. SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 121. VIVID IMAGING: KEY EXECUTIVES
  • TABLE 122. VIVID IMAGING: COMPANY SNAPSHOT
  • TABLE 123. VIVID IMAGING: PRODUCT SEGMENTS
  • TABLE 124. VIVID IMAGING: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030
  • FIGURE 02. SEGMENTATION OF CONTRAST INJECTOR SYSTEMS MARKET,2020-2030
  • FIGURE 03. TOP INVESTMENT POCKETS IN CONTRAST INJECTOR SYSTEMS MARKET (2021-2030)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW THREAT OF NEW ENTRANTS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW INTENSITY OF RIVALRY
  • FIGURE 08. LOW BARGAINING POWER OF BUYERS
  • FIGURE 09. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CONTRAST INJECTOR SYSTEMS MARKET FOR CONSUMABLES, BY COUNTRY 2020 AND 2030(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CONTRAST INJECTOR SYSTEMS MARKET FOR INJECTOR SYSTEMS, BY COUNTRY 2020 AND 2030(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CONTRAST INJECTOR SYSTEMS MARKET FOR ACCESSORIES, BY COUNTRY 2020 AND 2030(%)
  • FIGURE 14. CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CONTRAST INJECTOR SYSTEMS MARKET FOR RADIOLOGY, BY COUNTRY 2020 AND 2030(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CONTRAST INJECTOR SYSTEMS MARKET FOR INTERVENTIONAL RADIOLOGY, BY COUNTRY 2020 AND 2030(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CONTRAST INJECTOR SYSTEMS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY COUNTRY 2020 AND 2030(%)
  • FIGURE 18. CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CONTRAST INJECTOR SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY 2020 AND 2030(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CONTRAST INJECTOR SYSTEMS MARKET FOR DIAGNOSTICS CENTERS, BY COUNTRY 2020 AND 2030(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CONTRAST INJECTOR SYSTEMS MARKET FOR CLINICS, BY COUNTRY 2020 AND 2030(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CONTRAST INJECTOR SYSTEMS MARKET FOR OTHERS, BY COUNTRY 2020 AND 2030(%)
  • FIGURE 23. CONTRAST INJECTOR SYSTEMS MARKET BY REGION, 2020(%)
  • FIGURE 24. U.S. CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 25. CANADA CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 26. MEXICO CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 27. GERMANY CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 28. FRANCE CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 29. U.K. CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 30. ITALY CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 31. SPAIN CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 32. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 33. JAPAN CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 34. CHINA CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 35. INDIA CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 36. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 37. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 38. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 39. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 40. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 41. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET, 2020-2030 ($MILLION)
  • FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 46. COMPETITIVE DASHBOARD
  • FIGURE 47. COMPETITIVE HEATMAP: CONTRAST INJECTOR SYSTEMS MARKET
  • FIGURE 48. TOP PLAYER POSITIONING, 2020
  • FIGURE 49. GE HEALTHCARE: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 50. GE HEALTHCARE: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 51. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. GE HEALTHCARE: REVENUE SHARE BY REGION, 2022 (%)
目次
Product Code: A03632

According to a new report published by Allied Market Research, titled, "Contrast Injector Systems Market," The contrast injector systems market was valued at $755.57 million in 2020, and is estimated to reach $1.5 billion by 2030, growing at a CAGR of 7.3% from 2021 to 2030.

The major factors that drive the growth of the global contrast injector systems market include, rapid use of medical imaging process through contrast injectors, such as angiography, computed tomography, and magnetic resonance imaging procedures. In addition, increase in geriatric population and high prevalence of chronic diseases globally, propel the market growth. However, high cost associated with contrast injector systems and risks related to injector systems and contrast media are expected to restrict the market growth.

The contrast injector systems market is segmented on the basis of product type, application, end user, and region. According to product type, the market is divided into injector systems, consumables, and accessories. On the basis of application, the market is divided into interventional radiology, interventional cardiology, and radiology. On the basis of end user, the market is bifurcated, diagnostic centers, clinics, hospitals, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).

The Major companies profiled in the report include:, Bracco Imaging S.p.A, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd, Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the contrast injector systems market analysis from 2020 to 2030 to identify the prevailing contrast injector systems market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the contrast injector systems market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global contrast injector systems market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

  • Product Benchmarking / Product specification and applications
  • New Product Development/ Product Matrix of Key Players
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Product Type

  • Consumables
  • Injector Systems
  • Accessories

By Application

  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

By End User

  • Diagnostics centers
  • Clinics
  • Others
  • Hospitals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Medtron AG
    • Bayer Healthcare LLC
    • Nemoto Kyorindo Co. Ltd.
    • Sino Medical- Device Technology Co., Ltd.
    • Vivid Imaging
    • Ulrich GmbH & Co. KG
    • Guerbet Group
    • GE Healthcare
    • Bracco Imaging S.p.A
    • Shenzhen Seacrown Electromechanical Co., Ltd.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in geriatric population coupled with high prevalence of chronic diseases globally
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of contrast injectors systems and high risk associated with contrast injector system
    • 3.4.3. Opportunities
      • 3.4.3.1. Surge in healthcare expenditure and emergence of complex diseases in developing countries
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Consumables
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Injector Systems
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Accessories
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Radiology
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Interventional Radiology
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Interventional Cardiology
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: CONTRAST INJECTOR SYSTEMS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Diagnostics centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Clinics
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: CONTRAST INJECTOR SYSTEMS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Product Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Product Type
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Product Type
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Product Type
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Product Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Product Type
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Product Type
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. U.K.
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Product Type
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Product Type
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Product Type
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Product Type
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Product Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Product Type
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Product Type
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Product Type
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Product Type
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. Rest of Asia-Pacific
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Product Type
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Product Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Product Type
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Product Type
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Product Type
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Product Type
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2020

CHAPTER 9: COMPANY PROFILES

  • 9.1. Bracco Imaging S.p.A
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
  • 9.2. Bayer Healthcare LLC
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
  • 9.3. Guerbet Group
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Medtron AG
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
  • 9.5. Ulrich GmbH & Co. KG
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. GE Healthcare
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
  • 9.7. Shenzhen Seacrown Electromechanical Co., Ltd.
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Nemoto Kyorindo Co. Ltd.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Sino Medical- Device Technology Co., Ltd.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. Vivid Imaging
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio